UNSPSC 41202022: Epstein-barr virus serological reagents

In this classification, Epstein-barr virus serological reagents are devices used in test to identify specific Epstein-barr virus antibodies in serum. US FDA regulates Epstein-barr virus serological reagents under 21 CFR 866.3235 and under FDA product code GNP.

UNSPSC 41202022 Epstein-barr virus serological reagents is a Commodity code that encompasses HIV, Syphilis, and Hepatitis testing supplies and reagents procured by state health departments, county criminal justice agencies, and municipal public health programs. The recent solicitations tracked under this code span a much broader scope than the code name alone suggests — state and local buyers are acquiring rapid HIV test kits, HIV and Syphilis reagents and calibrators for automated laboratory analyzers, offender drug and specimen screening services bundled with testing infrastructure, and comprehensive clinical diagnostic laboratory services including blood chemistry reagents. The issuing bodies include the Illinois Department of Public Health Division of Laboratories (soliciting for Jackson County and Carbondale operations), the City of Austin Public Health Program, Collin County Community Supervision and Corrections Department (Texas), the Texas Department of Criminal Justice, and the University of Houston Student Health Center. The code shows activity across multiple issuing-body types — state health agencies dominating the recent opportunities, with county criminal justice and municipal public health programs as secondary buyers.

The geographic concentration centers on Texas and Illinois. Texas accounts for at least three recent solicitations: Collin County's $600,000 two-year RFP for offender specimen collection and drug testing services due July 23, 2026; the Texas Department of Criminal Justice forensic analysis RFP (696-IG-26-P034) due May 13, 2026; and a second TDCJ laboratory testing services solicitation (696-IG-26-P034) also due May 13, 2026. Illinois Department of Public Health has issued multiple procurements, including a Hepatitis/HIV/Syphilis 4th Generation Assay Screening and Instrument IFB (26482DPHOFCDIB50489) due March 16, 2026, and emergency sole-source awards to Abbott Laboratories Inc. for HIV and Syphilis reagents at $38,079.50 (executed February 3–May 3, 2026). The City of Austin HIV test kit IFB (IFB9100AAM1023) due July 17, 2026, seeking Abbott Determine HIV 1/2 Ag/Ab Combo Test kits, represents municipal activity. The code also captured a University of Houston clinical diagnostic laboratory services RFP (RFP-730-UofH-3109) due March 24, 2026, indicating health system procurement within the broader category.